01010nam0 22003373i 450 99643315220331620210817124855.019960221d1975----||||0itac50 baitaITa 1aA CubaErnesto Cardenalpresentazione di Ernesto BalducciAssisiCittadellastampa 1975313 p.ill.19 cmProgetti di liberazioneTrad. di: Filippo Gentiloni Silveri2001Progetti di liberazioneEn Cuba1860016Cuba1970Descrizioni e viaggiBNCFCUBADescrizioni e viaggiSec. 20.BNCFCUBAVita socialeBNCF917.2910464CARDENAL,Ernesto193466BALDUCCI,ErnestoITcbacbaREICAT996433152203316VI.7.B. 308704004 ISLAVI.7.B548692BKISLAEn Cuba1860016UNISA05334nam 22015973a 450 991034684730332120250203235435.09783039211883303921188910.3390/books978-3-03921-188-3(CKB)4920000000095167(oapen)https://directory.doabooks.org/handle/20.500.12854/42231(ScCtBLL)31976a50-5bac-40ac-8560-ccb1fd227e58(OCoLC)1126104408(oapen)doab42231(EXLCZ)99492000000009516720250203i20192019 uu engurmn|---annantxtrdacontentcrdamediacrrdacarrierBiological Potential and Medical Use of Secondary MetabolitesAna M. L. Seca, Diana Cláudia PintoMDPI - Multidisciplinary Digital Publishing Institute2019Basel, Switzerland :MDPI,2019.1 electronic resource (284 p.)9783039211876 3039211870 Many macro and micro species, from terrestrial and aquatic environments, produce structurally unique compounds and, in many countries, still are the primary sources of medicines. In fact, secondary metabolites are an important source of chemotherapeutic agents but are also lead compounds for synthetic modification and the optimization of biological activity. Therefore, the exploitation of secondary metabolites, or their inspired synthetic compounds, offers excellent opportunities for the pharmaceutical industry. This Medicines Special Issue focuses on the great potential of secondary metabolites for therapeutic application. The Special Issue contains 16 articles reporting relevant experimental results, and an overview of bioactive secondary metabolites, their biological effects, and new methodologies that improve and accelerate the process of obtained lead compounds with regard to new drug development. We would like to thank all 83 authors, from all over the world, for their valuable contributions to this Special Issue.ChemistrybicsscantitumortriterpenoidsseaweedsditerpenesBoswelliaantioxidant activityantiplasmodialMaytenus chiapensisphenolic derivativessecondary metabolitesmedicinal applicationsMalus x domesticapectincytotoxic activityxanthine oxidasephytochemistryantioxidantScabiosasugarssargaquinoic acidpentacyclic triterpenoidsanalysisantimicrobial and anticancer activityiridoidsTuscanyGC-MS(-)-rabdosiinkratomplant defensecembranoidstingenonedeoxypodophyllotoxinanticancerpristimerininflammationboswellic acidsplantsanti-inflammatorylegalizationMitragyna speciosaOcimum sanctumcordycepincytotoxicmedicineArtemisia speciesantimicrobial activitylignansArtemisia vachanicaCordyceps militarisfrankincenseancient varietiessargahydroquinoic acidTajikistanantiSMASHABTSpolyphenolstherapeuticsinfectious diseasesantibacterialnutraceuticstotal phenolicsLC-MS/MSinnate immunityHPLC-PADsarganaphthoquinoic acidbiosynthetic gene clustersDPPHEGCGcneorubenoidsPPAR-?bowel diseasesamentoflavonemolecular dockingsargachromenoic acidcannabinoidsflavonoidsessential oilsTCMHPLC-PDAascorbic acidantioxidantsLamiaceaenanoemulsionmalariatherapeutic usesquinonemethide triterpenoidsartemisininnatural productsbiological activitiesFRAPtoxicologydefensinsCelastraceaecannabisvector controlJuniperusanalytical determinationChemistrySeca Ana M. L1292427Pinto Diana CláudiaScCtBLLScCtBLLBOOK9910346847303321Biological Potential and Medical Use of Secondary Metabolites3022294UNINA